| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Detected but not Quantified |
|---|
| Creation Date | 2009-04-06 16:20:07 UTC |
|---|
| Update Date | 2023-02-21 17:17:41 UTC |
|---|
| HMDB ID | HMDB0012154 |
|---|
| Secondary Accession Numbers | |
|---|
| Metabolite Identification |
|---|
| Common Name | 3-Dehydrocarnitine |
|---|
| Description | 3-Dehydrocarnitine is a member of the carnitine family that is an intermediate in carnitine degradation. It can be formed from either D-carnitine or L-carnitine and the enzyme responsible for this oxidation reaction is (S)-carnitine 3-dehydrogenase (EC 1.1.1.254) or carnitine 3-dehydrogenase (EC 1.1.1.108), respectively. Carnitine is a quaternary ammonium compound biosynthesized from the amino acids lysine and methionine. In living cells, it is required for the transport of fatty acids from the cytosol into the mitochondria during the breakdown of lipids (or fats) for the generation of metabolic energy. |
|---|
| Structure | C[N+](C)(C)CC(=O)CC([O-])=O InChI=1S/C7H13NO3/c1-8(2,3)5-6(9)4-7(10)11/h4-5H2,1-3H3 |
|---|
| Synonyms | | Value | Source |
|---|
| 3-oxo-4-(Trimethylammonio)butanoate | ChEBI | | 3-oxo-4-(Trimethylammonio)butanoic acid | Generator | | 3-Carboxy-N,N,N-trimethyl-2-oxo-1-propanaminium | HMDB | | 3-Carboxy-N,N,N-trimethyl-2-oxopropan-1-aminium | HMDB |
|
|---|
| Chemical Formula | C7H13NO3 |
|---|
| Average Molecular Weight | 159.183 |
|---|
| Monoisotopic Molecular Weight | 159.089543287 |
|---|
| IUPAC Name | 3-oxo-4-(trimethylazaniumyl)butanoate |
|---|
| Traditional Name | 3-dehydrocarnitine |
|---|
| CAS Registry Number | 10457-99-5 |
|---|
| SMILES | C[N+](C)(C)CC(=O)CC([O-])=O |
|---|
| InChI Identifier | InChI=1S/C7H13NO3/c1-8(2,3)5-6(9)4-7(10)11/h4-5H2,1-3H3 |
|---|
| InChI Key | YNOWULSFLVIUDH-UHFFFAOYSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as short-chain keto acids and derivatives. These are keto acids with an alkyl chain the contains less than 6 carbon atoms. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Organic acids and derivatives |
|---|
| Class | Keto acids and derivatives |
|---|
| Sub Class | Short-chain keto acids and derivatives |
|---|
| Direct Parent | Short-chain keto acids and derivatives |
|---|
| Alternative Parents | |
|---|
| Substituents | - Beta-keto acid
- Short-chain keto acid
- 1,3-dicarbonyl compound
- Alpha-aminoketone
- Tetraalkylammonium salt
- Quaternary ammonium salt
- Carboxylic acid salt
- Ketone
- Carboxylic acid derivative
- Carboxylic acid
- Monocarboxylic acid or derivatives
- Organic nitrogen compound
- Organonitrogen compound
- Organooxygen compound
- Organic salt
- Hydrocarbon derivative
- Organic oxide
- Organopnictogen compound
- Carbonyl group
- Organic oxygen compound
- Amine
- Aliphatic acyclic compound
|
|---|
| Molecular Framework | Aliphatic acyclic compounds |
|---|
| External Descriptors | |
|---|
| Ontology |
|---|
| Physiological effect | Not Available |
|---|
| Disposition | |
|---|
| Process | Not Available |
|---|
| Role | Not Available |
|---|
| Physical Properties |
|---|
| State | Solid |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Experimental Chromatographic Properties | Not Available |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022. | 1.43 minutes | 32390414 | | Predicted by Siyang on May 30, 2022 | 8.8712 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 6.95 minutes | 32390414 | | AjsUoB = Accucore 150 Amide HILIC with 10mM Ammonium Formate, 0.1% Formic Acid | 301.9 seconds | 40023050 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 620.6 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 261.6 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 90.6 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 166.4 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 49.2 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 228.8 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 270.7 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 732.7 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 726.0 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 40.7 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 1016.5 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 180.4 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 182.0 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 567.1 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 384.4 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 117.7 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| 3-Dehydrocarnitine,1TMS,isomer #1 | C[N+](C)(C)CC(=CC(=O)[O-])O[Si](C)(C)C | 1348.6 | Semi standard non polar | 33892256 | | 3-Dehydrocarnitine,1TMS,isomer #1 | C[N+](C)(C)CC(=CC(=O)[O-])O[Si](C)(C)C | 1273.0 | Standard non polar | 33892256 | | 3-Dehydrocarnitine,1TMS,isomer #1 | C[N+](C)(C)CC(=CC(=O)[O-])O[Si](C)(C)C | 1560.0 | Standard polar | 33892256 | | 3-Dehydrocarnitine,1TMS,isomer #2 | C[N+](C)(C)C=C(CC(=O)[O-])O[Si](C)(C)C | 1314.7 | Semi standard non polar | 33892256 | | 3-Dehydrocarnitine,1TMS,isomer #2 | C[N+](C)(C)C=C(CC(=O)[O-])O[Si](C)(C)C | 1318.0 | Standard non polar | 33892256 | | 3-Dehydrocarnitine,1TMS,isomer #2 | C[N+](C)(C)C=C(CC(=O)[O-])O[Si](C)(C)C | 1497.0 | Standard polar | 33892256 | | 3-Dehydrocarnitine,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC(=CC(=O)[O-])C[N+](C)(C)C | 1567.3 | Semi standard non polar | 33892256 | | 3-Dehydrocarnitine,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC(=CC(=O)[O-])C[N+](C)(C)C | 1478.7 | Standard non polar | 33892256 | | 3-Dehydrocarnitine,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC(=CC(=O)[O-])C[N+](C)(C)C | 1680.2 | Standard polar | 33892256 | | 3-Dehydrocarnitine,1TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)OC(=C[N+](C)(C)C)CC(=O)[O-] | 1532.6 | Semi standard non polar | 33892256 | | 3-Dehydrocarnitine,1TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)OC(=C[N+](C)(C)C)CC(=O)[O-] | 1534.2 | Standard non polar | 33892256 | | 3-Dehydrocarnitine,1TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)OC(=C[N+](C)(C)C)CC(=O)[O-] | 1629.3 | Standard polar | 33892256 |
|
|---|
| Disease References | | Colorectal cancer |
|---|
- Goedert JJ, Sampson JN, Moore SC, Xiao Q, Xiong X, Hayes RB, Ahn J, Shi J, Sinha R: Fecal metabolomics: assay performance and association with colorectal cancer. Carcinogenesis. 2014 Sep;35(9):2089-96. doi: 10.1093/carcin/bgu131. Epub 2014 Jul 18. [PubMed:25037050 ]
- Brown DG, Rao S, Weir TL, O'Malia J, Bazan M, Brown RJ, Ryan EP: Metabolomics and metabolic pathway networks from human colorectal cancers, adjacent mucosa, and stool. Cancer Metab. 2016 Jun 6;4:11. doi: 10.1186/s40170-016-0151-y. eCollection 2016. [PubMed:27275383 ]
- Sinha R, Ahn J, Sampson JN, Shi J, Yu G, Xiong X, Hayes RB, Goedert JJ: Fecal Microbiota, Fecal Metabolome, and Colorectal Cancer Interrelations. PLoS One. 2016 Mar 25;11(3):e0152126. doi: 10.1371/journal.pone.0152126. eCollection 2016. [PubMed:27015276 ]
|
|
|---|